STAT+: Former executives of device maker Zynex Medical indicted for fraud

STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?

STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device

STAT+: How health care could gum up Trump’s reconciliation push

STAT+: Trump administration prepares 100% tariffs on some imported drugs

STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along

STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request

STAT+: Biotech investors’ plea to Trump, and a busy M&A week

STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds

Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like?

STAT reporter goes up against radiologists to spot deepfake X-rays

STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more

STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome

STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more

STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more